| Title | Intervention |
NCT ID |
Sponsor | Status |
|---|---|---|---|---|
| MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer | Breast surgery, Magnetic resonance imaging, Mammography | NCT01805076 | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Reproductive Health Program in Patients With Cancer | educational intervention, quality-of-life assessment, questionnaire administration | NCT01806129 | Eastern Cooperative Oncology Group | Active, not recruiting |
| A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) | anastrozole, questionnaire administration, laboratory biomarker analysis, pharmacogenomic studies | NCT01824836 | Eastern Cooperative Oncology Group | Active, not recruiting |
| Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In... | metformin hydrochloride, placebo | NCT01905046 | Alliance for Clinical Trials in Oncology | Recruiting |
| Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk | Metformin, Placebo | NCT02028221 | University of Arizona | Active, not recruiting |
| Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer | Comprehensive Geriatric Assessment, Quality-of-Life Assessment, Survey Administration | NCT02054741 | Supriya Mohile | Active, not recruiting |
| Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation | Pamidronate, Calcium and vitamin D | NCT02074631 | Masonic Cancer Center, University of Minnesota | Recruiting |
| Adaptation of Individual Meaning-Centered Psychotherapy for Chinese Immigrant Cancer Patients | Adaptation of IMCP for Chinese Immigrant Cancer Patients, In-depth Patient Interviews | NCT02112188 | Memorial Sloan Kettering Cancer Center | Recruiting |
| Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps | Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline | NCT02134925 | National Cancer Institute (NCI) | Active, not recruiting |
| Iloprost in Preventing Lung Cancer in Former Smokers | Iloprost, Quality-of-Life Assessment, Questionnaire Administration, Placebo Administration | NCT02237183 | National Cancer Institute (NCI) | Active, not recruiting |
Why I Joined a Clinical Trial
I was the first patient who Dr. Abraham enrolled on the NSABP B-31 clinical trial (chemo vs chemo + Trastuzumab in HER-2 positive breast cancer). I am grateful to him for presenting me with the opportunity to join the study 20 years ago in March 2001 and that I had the courage to participate, as I continue to do well to this day. This clinical trial ended up changing the landscape of treatment for future patients with breast cancer.